Navigation Links
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
Date:7/19/2009

, n=290), 1 mg/kg belimumab (BLISS-52, n=288), or placebo (BLISS-52, n=287). Patients are dosed intravenously on Days 0, 14 and 28, then every 28 days thereafter for the duration of the study. All receive standard of care therapy in addition to the study medication. Safety is reviewed by an independent Data Monitoring Committee throughout both studies.

About BENLYSTA (belimumab)

Belimumab is an investigational human monoclonal antibody drug that specifically recognizes and inhibits the biological activity of B-lymphocyte stimulator, or BLyS(R). BLyS is a naturally occurring protein discovered by HGS that is required for the development of B-lymphocyte cells into mature plasma B cells. Plasma B cells produce antibodies, the body's first line of defense against infection. In lupus and certain other autoimmune diseases, elevated levels of BLyS are believed to contribute to the production of autoantibodies - antibodies that attack and destroy the body's own healthy tissues. The presence of autoantibodies appears to correlate with disease severity. Preclinical and clinical studies suggest that belimumab can reduce autoantibody levels in SLE. BLISS 52 results suggest that belimumab can reduce SLE disease activity, and a second Phase 3 trial, BLISS-76, is underway to confirm these results.

About the Collaboration with GSK

In August 2006, HGS and GSK entered into a definitive co-development and co-commercialization agreement under which HGS has responsibility for conducting the belimumab Phase 3 trials, with assistance from GSK. The companies will share equally in Phase 3/4 development costs, sales and marketing expenses, and profits of any product commercialized under the current agreement.

About Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic, life-threatening autoimmune disease. Approximately
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend of twelve cents per outstanding share, ... at the close of business on June 12, 2015. ... in 1906, Kewaunee Scientific Corporation is a recognized global ... healthcare, and technical furniture products. Products include steel, wood, ...
(Date:6/2/2015)... REPORT HIGHLIGHTS The global market for ... This market is expected to increase from more than $4.1 ... compound annual growth rate (CAGR) of 13.6% over the five-year ... An in-depth analysis of the global markets and ... from 2013, estimates for 2014, and projections of compounds annual ...
(Date:6/2/2015)... , June 02, 2015 Research ... addition of Jain PharmaBiotech,s new report "Drug ... Markets and Companies" to their offering. ... system (CNS) is a challenge in the treatment ... into the CNS or administered systematically (e.g., by ...
Breaking Medicine Technology:Global Markets and Technologies for Medical Lasers 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3
... Genmab A/S (OMX:,GEN) announced today a Phase ... of ofatumumab (HuMax-CD20(R)) in rheumatoid arthritis (RA),patients, stable ... which,will consist of two parts and include approximately ... addition of a subcutaneous method of administrating ofatumumab ...
... and benefits of early treatment ... with liraglutide versus glimepiride, SAN FRANCISCO, June ... the American Diabetes Association (ADA),demonstrated that once-daily liraglutide when taken ... with type 2 diabetes, as compared to glimepiride, a widely ...
Cached Medicine Technology:Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study 2Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study 3Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 2Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 3Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 4
(Date:6/3/2015)... Veatch Consulting Services is excited to announce their ... business in April 2006, they have made it a ... Each and every year they have worked diligently in ... say that they are off to a great start ... this year is the Customer Review site veatchconsultingreviews.weebly.com. At ...
(Date:6/3/2015)... Israel (PRWEB) June 03, 2015 ... emergency mass-notification, multi-channel solutions, reported of its "behind-the-scenes" ... the past few months. Since March this year, ... has been inflicting the South-American country, putting millions ... ash and gas into the atmosphere. "evigilo's technology, ...
(Date:6/2/2015)... (PRWEB) June 03, 2015 BALTIMORE, Md. ... to write a book about wellness after being diagnosed ... she believes that through lifestyle changes which enhance health, ... In “ A Wellspring for Wellness ,” she ... diseases. , This book provides an overview of ...
(Date:6/2/2015)... The organic cotton market is again growing according ... conducted by Textile Exchange, an international nonprofit organization committed ... today, encompasses extensive data about organic cotton from seed ... takes the opportunity to celebrate those who are building ... last several years have been complicated for the organic ...
(Date:6/2/2015)... Kan. (PRWEB) June 02, 2015 Concorde ... Bell as President and COO. Bell will manage day-to-day ... , “I’m looking forward to the opportunity to help ... students,” Bell said. “I joined Concorde in part due ... Institute that highlighted Concorde colleges in Memphis and Portland.” ...
Breaking Medicine News(10 mins):Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Thousands of Lives Saved, Millions Protected in Chile 2Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5Health News:Concorde Career Colleges Announces New President and COO 2
... poultry made its way to the food chain via the ... strain// of bird flu in early February this year. ... almost 850 tons of turkey had to pass through the ... the interim period between outbreak of the avian influenza and ...
... Haikerwal, today urged more Australians to donate blood and donate ... ,Dr Haikerwal said the AMA strongly supports the ... designed to raise the number of Australian blood donors and ... year. ,“Blood donors save lives,” Dr Haikerwal ...
... are varied reactions to the U.S panel hearing ... , The Senate Health, Education, Labor and ... Food and Drug Administration legal authority to approve alternative ... Yet it has drawn both brickbats and ...
... article published in the prestigious international journal 'The Lancet' by ... Darwin// has revealed a breakthrough in the battle to treat ... the worlds population. ,There are two major strains ... attention focuses on the more virulent P. falciparum, vivax malaria ...
... in a duck farm in Chonan, in central South Korea. ... bird flu on Thursday//. The cause was identified as "highly ... bird flu outbreak since November reported in South Korea. H5N1 ... Korea. ,The culling of over 55,000 poultry will ...
... According to statistics over one lac people Indians are diagnosed ... die as they do not get timely treatment. ... Check-up package in connection with World Kidney Day-2007. The camp ... and urine analysis for random glucose and creatinine. ...
Cached Medicine News:Health News:Generic Biologics – U.S Panel Hearing Draws Mixed Response 2Health News:Researchers Discover Breakthrough in Malaria Treatment 2
Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....
... Series Spectrophotometer is truly ... UV-VIS instrumentation. The latest ... into a radically new ... and performance unprecedented in ...
... the user to quickly and accurately count bacteria ... counting or manual counting. An optional 1.5X auxiliary ... to 3.0X. The adjustable focusing rod allows the ... The lens also rotates a full 360 for ...
The Accucount 2000 is designed to automatically count microscopic objects in a field displaying totals on a highly visible digital readout....
Medicine Products: